Retrospective Chart Review to evaluate the safety profile of ceftobiprole in patients with impaired hepatic or renal function or immunosuppression (RETRACE)

08/07/2019
03/01/2024
EU PAS number:
EUPAS30444
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.17 MB - PDF) View document
Study results
Study results
English (118.65 KB - PDF) View document
Study report
Other information